Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates

被引:81
作者
Nijssen, S
Florijn, A
Bonten, MJM
Schmitz, FJ
Verhoef, J
Fluit, AC
机构
[1] Univ Utrecht, Med Ctr, Dept Internal Med, Div Emergency Med & Infect Dis, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Eijkman Winkler Inst Med Microbiol, NL-3508 GA Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Patient Care, NL-3508 GA Utrecht, Netherlands
关键词
SENTRY; beta-lactam antibiotics; Enterobacteriaceae; resistance; ESBL;
D O I
10.1016/j.ijantimicag.2004.08.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In vitro susceptibility to 15 P-lactam antibiotics was evaluated using Enterobacteriaceae isolated during the SENTRY Antimicrobial Surveillance Program. Piperacillin/tazobactam was the most active penicillin against Escherichia coli, Proteus mirabilis, Klebsiella oxytoca and Klebsiella pneumoniae (94.9%, 98.3%, 87.4% and 82.9% of isolates susceptible). Of the cephalosporins, cefepime was most effective against Escherichia coli, Proteus mirabilis and Enterobacter cloocae (99.2%, 96.3% and 95.2% of isolates susceptible, respectively) and cefoxitin against Klebsiella oxytoca and Klebsiella pneumoniae (98.6% and 95.6% of isolates susceptible). Carbapenems had excellent activity (greater than or equal to99.5% of all isolates). ESBL-production was confirmed with the ESBL-Etest and disk diffusion test in 1.3% of Escherichia coli isolates, 18.4% of Klebsiella pneumoniae, 12.6% of Klebsiella oxytoca and 5.3% of Proteus mirabilis isolates. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:585 / 591
页数:7
相关论文
共 21 条
[1]   Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: Seek and you may find [J].
Coudron, PE ;
Moland, ES ;
Sanders, CC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (10) :2593-2597
[2]   Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center [J].
Emery, CL ;
Weymouth, LA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (08) :2061-2067
[3]   Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases [J].
Florijn, A ;
Nijssen, S ;
Schmitz, FJ ;
Verhoef, J ;
Fluit, AC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (03) :241-243
[4]   MORE EXTENDED-SPECTRUM BETA-LACTAMASES [J].
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1697-1704
[5]  
JARLIER V, 1988, REV INFECT DIS, V10, P867
[6]   Restoration-based compensation measures in natural resource liability statutes [J].
Jones, CA ;
Pease, KA .
CONTEMPORARY ECONOMIC POLICY, 1997, 15 (04) :111-122
[8]   Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) [J].
Jones, RN ;
Croco, MAT ;
Kugler, KC ;
Pfaller, MA ;
Beach, ML .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 37 (02) :115-125
[9]  
Jones Ronald N., 1996, American Journal of Medicine, V100, p3S, DOI 10.1016/S0002-9343(96)00102-7
[10]  
Kenneth S, 1997, CLIN MICROBIOL INFEC, V3, P549